-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the General Office of the People's Government of Shanxi Province issued the "Implementation Opinions on Promoting the Normalized and Institutionalized Development of Centralized and Volume Procurement of Drugs and the Classified and Centralized Procurement of Medical Consumables" (hereinafter referred to as the "Opinions").
Following the release of the “Implementation Plan for the Centralized Procurement and Use of Pharmaceutical Consumables” in 2019, Shanxi Province issued the plan again to further promote the normalization of centralized procurement on the basis of the original, and explore the centralized and classified procurement of new medical consumables.
Expansion of centralized procurement
Regarding the scope of centralized procurement, the "Opinions" of Shanxi Province proposed: For high-value medical consumables with large clinical usage, high procurement amount, mature clinical use, and relatively sufficient competition, we should explore and carry out centralized procurement of high-value medical consumables by category.
The "Opinions" require that the varieties included in the "Key Management List of High-Value Medical Consumables" by the country and Shanxi Province and those that have been purchased in quantities in other provinces should be included in the procurement scope first.
In addition, the key supervision of the selected products will be carried out, and the quality supervision of the production, circulation and use of the selected products will be strengthened in accordance with the requirements of "the most stringent standards, the most stringent supervision, the most severe penalties, and the most serious accountability".
Dealing with the quality problems of pharmaceutical consumables in accordance with laws and regulations, from production to use, the supervision of all links will be more stringent!
Public medical institutions can jointly carry out centralized procurement
In addition, this time Shanxi Province also requires that the procurement work be carried out by tiers and categorizations, and in accordance with the work path of tiered advancement, batch development, and categorized exploration, promote the construction of a multi-level, multi-form alliance and joint procurement mechanism.
On the basis of fully implementing the results of the national organization of centralized procurement of pharmaceutical consumables, actively join the inter-provincial alliance to jointly carry out centralized procurement of pharmaceutical consumables.
In addition, for pharmaceutical consumables that have not been included in the scope of centralized procurement by government organizations, the consumption is relatively small, or the specialized drug consumables are encouraged to jointly carry out mass procurement by public medical institutions.
As we all know, most of the alliance's volume purchases are at the city level, and they are concentrated on large-volume and high-priced products.
Ensure the payment is settled, and the payment must be returned within 60 days
There is also the issue of payment settlement, which has always been the most troublesome issue for all companies.
The “Opinions” of Shanxi Province also proposed to establish a prepayment mechanism for centralized procurement of pharmaceuticals and consumables on the basis of the total budget of the medical insurance fund in order to ensure the settlement of the goods.
Medical institutions are required to settle the payment in time with the company in accordance with the purchase contract, and the settlement time shall not exceed the end of the next month after the delivery is accepted.
At the same time, actively explore ways to promote direct settlement between medical insurance funds and pharmaceutical companies through the establishment of an electronic settlement center for pharmaceutical consumables in provincial-level centralized procurement agencies for pharmaceutical consumables.
Bulk procurement has entered a new era, affecting all medical equipment personnel
For a long time, most of the varieties purchased with volume are some products with large volume and mature clinical use.
This time Shanxi Province even directly included medical consumables in the joint procurement of medical institutions.
Looking at the policy requirements in the past few years, it is not difficult to find that joint procurement by medical institutions has long been a strong grasp.
As early as 2019, the National Health Commission issued the "Notice on Promoting the Construction of a Compact County-level Medical and Health Community", and the community will be established in 500 counties and districts by the end of 2020.
It also specifically requires that the county medical community implement unified management of pharmaceutical consumables, unified drug catalogs, unified procurement and distribution, and unified payment for goods.
There is no doubt that under the leadership of the county medical community, products that are not included in the provincial-level procurement with a small amount can be collected through the joint centralized procurement of the county medical community.
In the future, prices of large varieties will be bargained across the board, and joint price reductions of small varieties will become a new trend.
For all enterprises and distributors, great changes in the market will eventually be inevitable.
It is very important to quickly adapt and accelerate the transformation to find a foothold in the market.
(Medical Device Dealers Alliance )
A few days ago, the General Office of the People's Government of Shanxi Province issued the "Implementation Opinions on Promoting the Normalized and Institutionalized Development of Centralized and Volume Procurement of Drugs and the Classified and Centralized Procurement of Medical Consumables" (hereinafter referred to as the "Opinions").
Following the release of the “Implementation Plan for the Centralized Procurement and Use of Pharmaceutical Consumables” in 2019, Shanxi Province issued the plan again to further promote the normalization of centralized procurement on the basis of the original, and explore the centralized and classified procurement of new medical consumables.
Guide the prices of pharmaceutical consumables to return to a reasonable level, effectively reducing the burden of medical expenses for the masses.
Expansion of centralized procurement
Regarding the scope of centralized procurement, the "Opinions" of Shanxi Province proposed: For high-value medical consumables with large clinical usage, high procurement amount, mature clinical use, and relatively sufficient competition, we should explore and carry out centralized procurement of high-value medical consumables by category.
The "Opinions" require that the varieties included in the "Key Management List of High-Value Medical Consumables" by the country and Shanxi Province and those that have been purchased in quantities in other provinces should be included in the procurement scope first.
All public medical institutions in the province (including military medical institutions, the same below) should participate in the centralized procurement of pharmaceuticals and consumables.
In addition, the key supervision of the selected products will be carried out, and the quality supervision of the production, circulation and use of the selected products will be strengthened in accordance with the requirements of "the most stringent standards, the most stringent supervision, the most severe penalties, and the most serious accountability".
Accelerate the construction of a traceability system for the entire production, circulation and use of pharmaceutical consumables, and basically realize that the selected pharmaceutical consumables can be queried and traced throughout the entire process.
Dealing with the quality problems of pharmaceutical consumables in accordance with laws and regulations, from production to use, the supervision of all links will be more stringent!
Public medical institutions can jointly carry out centralized procurement
In addition, this time Shanxi Province also requires that the procurement work be carried out by tiers and categorizations, and in accordance with the work path of tiered advancement, batch development, and categorized exploration, promote the construction of a multi-level, multi-form alliance and joint procurement mechanism.
On the basis of fully implementing the results of the national organization of centralized procurement of pharmaceutical consumables, actively join the inter-provincial alliance to jointly carry out centralized procurement of pharmaceutical consumables.
At the same time, organize the implementation of centralized procurement of pharmaceutical consumables within the province and encourage the municipal alliance to carry out centralized procurement.
Quantity purchase.
In addition, for pharmaceutical consumables that have not been included in the scope of centralized procurement by government organizations, the consumption is relatively small, or the specialized drug consumables are encouraged to jointly carry out mass procurement by public medical institutions.
As we all know, most of the alliance's volume purchases are at the city level, and they are concentrated on large-volume and high-priced products.
However, this time Shanxi Province particularly emphasized that in addition to varieties with large dosages and mature clinical use, public medical institutions can also carry out joint collections of varieties with smaller dosages.
I have to say that such a situation is a bit irritating.
Shocking!
Ensure the payment is settled, and the payment must be returned within 60 days
There is also the issue of payment settlement, which has always been the most troublesome issue for all companies.
The “Opinions” of Shanxi Province also proposed to establish a prepayment mechanism for centralized procurement of pharmaceuticals and consumables on the basis of the total budget of the medical insurance fund in order to ensure the settlement of the goods.
The medical insurance fund shall be paid in advance to medical institutions not less than 30% of the agreed annual purchase amount.
, Ensure payment settlement.
Medical institutions are required to settle the payment in time with the company in accordance with the purchase contract, and the settlement time shall not exceed the end of the next month after the delivery is accepted.
At the same time, actively explore ways to promote direct settlement between medical insurance funds and pharmaceutical companies through the establishment of an electronic settlement center for pharmaceutical consumables in provincial-level centralized procurement agencies for pharmaceutical consumables.
Bulk procurement has entered a new era, affecting all medical equipment personnel
For a long time, most of the varieties purchased with volume are some products with large volume and mature clinical use.
However, on January 28 this year, the General Office of the State Council issued the "Opinions on Promoting the Normalized and Institutionalized Development of Centralized Drug Purchases "(Guobanfa [2021] No.
2), it has been mentioned that for drugs that have not been included in the scope of centralized procurement of government organizations, medical institutions can independently or entrust procurement on the provincial centralized drug procurement platform.
This time Shanxi Province even directly included medical consumables in the joint procurement of medical institutions.
Perhaps everyone may still be wondering how the medical institutions, as the main procurement body, should form an alliance due to their small size?
Looking at the policy requirements in the past few years, it is not difficult to find that joint procurement by medical institutions has long been a strong grasp.
As early as 2019, the National Health Commission issued the "Notice on Promoting the Construction of a Compact County-level Medical and Health Community", and the community will be established in 500 counties and districts by the end of 2020.
It also specifically requires that the county medical community implement unified management of pharmaceutical consumables, unified drug catalogs, unified procurement and distribution, and unified payment for goods.
There is no doubt that under the leadership of the county medical community, products that are not included in the provincial-level procurement with a small amount can be collected through the joint centralized procurement of the county medical community.
In the future, prices of large varieties will be bargained across the board, and joint price reductions of small varieties will become a new trend.
For all enterprises and distributors, great changes in the market will eventually be inevitable.
It is very important to quickly adapt and accelerate the transformation to find a foothold in the market.
(Medical Device Dealers Alliance )